Kristina Masson
Förmögenhet: 618 149 $ per 2026-05-31
Förmögenhet: 618 149 $ per 2026-05-31
Kristina Masson is the founder of Acrivon Therapeutics, Inc., founded in 2018, and holds the title of Director & Executive VP-Business Operations since 2022.
Dr. Masson completed graduate and doctorate degrees at the University of Lund.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-21 | 386 343 ( 0,9 % ) | 618 149 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Grundare | 2018-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 2 |
|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån